JP2023501352A5 - - Google Patents
Info
- Publication number
- JP2023501352A5 JP2023501352A5 JP2022526072A JP2022526072A JP2023501352A5 JP 2023501352 A5 JP2023501352 A5 JP 2023501352A5 JP 2022526072 A JP2022526072 A JP 2022526072A JP 2022526072 A JP2022526072 A JP 2022526072A JP 2023501352 A5 JP2023501352 A5 JP 2023501352A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- sequence
- modified
- modified oligonucleotide
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962932758P | 2019-11-08 | 2019-11-08 | |
| US62/932,758 | 2019-11-08 | ||
| US202063056969P | 2020-07-27 | 2020-07-27 | |
| US63/056,969 | 2020-07-27 | ||
| PCT/US2020/059506 WO2021092459A1 (en) | 2019-11-08 | 2020-11-06 | Compounds and methods for reducing spdef expression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023501352A JP2023501352A (ja) | 2023-01-18 |
| JP2023501352A5 true JP2023501352A5 (https=) | 2023-11-14 |
Family
ID=75849553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022526072A Pending JP2023501352A (ja) | 2019-11-08 | 2020-11-06 | Ｓｐｄｅｆ発現を低減するための化合物及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20210139906A1 (https=) |
| EP (1) | EP4054655A4 (https=) |
| JP (1) | JP2023501352A (https=) |
| TW (1) | TW202128999A (https=) |
| WO (1) | WO2021092459A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4168549A4 (en) * | 2020-06-19 | 2024-10-09 | Ionis Pharmaceuticals, Inc. | COMPOUNDS AND METHODS FOR PMP22 MODULATION |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010010934A1 (en) * | 1998-07-31 | 2001-08-02 | Towia Aron Libermann | Prostate derived ets factor |
| US6821724B1 (en) * | 1998-09-17 | 2004-11-23 | Affymetrix, Inc. | Methods of genetic analysis using nucleic acid arrays |
| AU2003295600A1 (en) * | 2002-11-14 | 2004-06-15 | Dharmacon, Inc. | Functional and hyperfunctional sirna |
| US20060257851A1 (en) * | 2002-11-26 | 2006-11-16 | Itzhak Bentwich | Bioinformatically detectable group of novel viral regulatory genes and uses thereof |
| US20070009899A1 (en) * | 2003-10-02 | 2007-01-11 | Mounts William M | Nucleic acid arrays for detecting gene expression in animal models of inflammatory diseases |
| US20050244851A1 (en) * | 2004-01-13 | 2005-11-03 | Affymetrix, Inc. | Methods of analysis of alternative splicing in human |
| US20050221354A1 (en) * | 2004-02-18 | 2005-10-06 | Wyeth | Nucleic acid arrays for monitoring expression profiles of drug target genes |
| US20070048756A1 (en) * | 2005-04-18 | 2007-03-01 | Affymetrix, Inc. | Methods for whole genome association studies |
| AU2007225238A1 (en) * | 2006-03-10 | 2007-09-20 | Wyeth | Microarray for monitoring gene expression in multiple strains of Streptococcus pneumoniae |
| US20090123928A1 (en) * | 2007-10-11 | 2009-05-14 | The Johns Hopkins University | Genomic Landscapes of Human Breast and Colorectal Cancers |
| EP2220230A2 (en) * | 2007-11-09 | 2010-08-25 | Isis Pharmaceuticals, Inc. | Modulation of factor 9 expression |
| US8257716B2 (en) * | 2007-12-21 | 2012-09-04 | Ashwani Sood | Anti-PDEF antibodies and uses thereof |
| WO2010115278A1 (en) * | 2009-04-06 | 2010-10-14 | University Of Saskatchewan | Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection |
| US20120053112A1 (en) * | 2009-05-05 | 2012-03-01 | Children's Hospital Medical Center | Methods and compositions related to the regulation of goblet cell differentiation, mucus production and mucus secretion |
| US20140004565A1 (en) * | 2009-07-06 | 2014-01-02 | Alnylam Pharmaceuticals, Inc. | Cell-based bioprocessing |
| US9920317B2 (en) * | 2010-11-12 | 2018-03-20 | The General Hospital Corporation | Polycomb-associated non-coding RNAs |
| CA2817256A1 (en) * | 2010-11-12 | 2012-05-18 | The General Hospital Corporation | Polycomb-associated non-coding rnas |
| AR092982A1 (es) * | 2012-10-11 | 2015-05-13 | Isis Pharmaceuticals Inc | Modulacion de la expresion de receptores androgenicos |
| US9988626B2 (en) * | 2013-07-29 | 2018-06-05 | Universität Zu Köln | Neurocalcin delta inhibitors and therapeutic and non-therapeutic uses thereof |
| CA2954791C (en) * | 2014-07-14 | 2025-11-18 | The Regents Of The University Of California | CRISPR/CAS TRANSCRIPTIONAL MODULATION |
| US20180305689A1 (en) * | 2015-04-22 | 2018-10-25 | Mina Therapeutics Limited | Sarna compositions and methods of use |
| US20170343551A1 (en) * | 2016-04-05 | 2017-11-30 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Method of diagnosing and treating prostate cancer |
| TWI840345B (zh) * | 2018-03-02 | 2024-05-01 | 美商Ionis製藥公司 | Irf4表現之調節劑 |
-
2020
- 2020-11-06 JP JP2022526072A patent/JP2023501352A/ja active Pending
- 2020-11-06 WO PCT/US2020/059506 patent/WO2021092459A1/en not_active Ceased
- 2020-11-06 EP EP20886021.3A patent/EP4054655A4/en active Pending
- 2020-11-09 TW TW109139080A patent/TW202128999A/zh unknown
-
2021
- 2021-01-12 US US17/147,215 patent/US20210139906A1/en not_active Abandoned
- 2021-10-22 US US17/508,516 patent/US20220290137A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021530204A5 (https=) | ||
| ES2959815T3 (es) | Edición génica selectiva de alelo y usos de la misma | |
| JP2022515193A5 (https=) | ||
| TW202208625A (zh) | 經修飾之短干擾核酸(siNA)分子及其用途 | |
| JP2023536974A5 (https=) | ||
| JP2022518929A5 (https=) | ||
| JP2022520986A5 (https=) | ||
| JP2022527105A5 (https=) | ||
| JP2022533358A5 (https=) | ||
| JP2021526823A5 (https=) | ||
| JP2023537798A5 (https=) | ||
| JP2021522800A5 (https=) | ||
| TW202113079A (zh) | 經修飾之間隙子寡核苷酸及其使用方法 | |
| JP2019525918A5 (https=) | ||
| JP2024516096A5 (https=) | ||
| JP2021511072A5 (https=) | ||
| JP2010500291A5 (https=) | ||
| KR20200104347A (ko) | 포스포로디티오에이트 인터뉴클레오시드 연결을 포함하는 갭머 올리고뉴클레오티드 | |
| JP2024516183A5 (https=) | ||
| CN114828859A (zh) | siRNA缀合物、双链siRNA缀合物及其盐和应用 | |
| ES2301659T3 (es) | Metodos para aumentar la eficacia in vivo de oligonucleotidos e inhibir la inflamacion en mamiferos. | |
| JP2023501352A5 (https=) | ||
| JP2022552192A (ja) | レチノイン酸誘導遺伝子ｉタンパク質に結合する核酸化合物 | |
| JP2021524277A (ja) | Ｒｔｅｌ１発現の調節用のオリゴヌクレオチド | |
| WO1994022888A1 (en) | Bifunctional nucleosides, oligomers thereof, and methods of making and using the same |